LENSAR Announces Application for Certification of the ALLY™ Adaptive Cataract Treatment System in the EU

ORLANDO, Fla.--(BUSINESS WIRE)--LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, today announced the application for certification of the ALLY™ Adaptive Cataract Treatment System (“ALLY” or the “ALLY System”) in the European Union. “Following the FDA clearance of ALLY in June 2022 and recent U.S. commercial launch, this is another important step in our effort to b